ANTES B+ Clinical Trial

PHASE4

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Delays in the opening and activation of participating sites, and a low recruitment rate, with only 48 participants enrolled over the course of one year

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Trelegy Ellipta 100/62.5/25Mcg Inh 30D
DRUG: Brimica
DRUG: Duaklir
DRUG: Ultibro
DRUG: Ulunar
DRUG: Xoterna
DRUG: Anoro
DRUG: Laventair
DRUG: Spiolto Respimat
DRUG: Yanimo
DRUG: Foradil
DRUG: Broncoral
DRUG: Formoterol stada
DRUG: Oxis
DRUG: Formatris
DRUG: Formoterol Aldo
DRUG: Onbrez
DRUG: Oslif
DRUG: Hirobriz
DRUG: Striverdi

Sponsor

Fundacio Privada Mon Clinic Barcelona

Collaborators

[object Object]